
{{Act of Congress
| congress       = 113
| session        = 1
| title          = To direct the Commissioner of Food and Drugs to modify the approval of any drug containing controlled-release oxycodone hydrochloride to limit such approval to use for the relief of severe-only instead of moderate-to-severe pain, and for other purposes.
| year           = 2013
| month          = 03
| day            = 21
| bill           = 1366
| billtype       = hr
| purpose        = To direct the Commissioner of Food and Drugs to modify the approval of any drug containing controlled-release oxycodone hydrochloride to limit such approval to use for the relief of severe-only instead of moderate-to-severe pain, and for other purposes.
}}
113 HR 1366 IH: Stop Oxy Abuse Act of 2013U.S. House of Representatives2013-03-21text/xmlENPursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
{{Center|113th CONGRESS}}


{{Center|1st Session}}


{{Center|H. R. 1366}}


{{Center|IN THE HOUSE OF REPRESENTATIVES}}


{{Center|March 21, 2013}}


{{Center|
[[w:Stephen Lynch (politician)|Mr. Lynch]] (for himself,
[[w:Mike Fitzpatrick|Mr. Fitzpatrick]] ,
[[w:Hal Rogers|Mr. Rogers of Kentucky]] ,
[[w:Nick Rahall|Mr. Rahall]] ,
[[w:William R. Keating|Mr. Keating]] ,
[[w:Frank Wolf|Mr. Wolf]] , and
[[w:Louise Slaughter|Ms. Slaughter]] ) introduced the following bill; which was referred to the [[w:United States House Committee on Energy and Commerce|Committee on Energy and Commerce]] }}


{{Center|A BILL}}

To direct the Commissioner of Food and Drugs to modify the approval of any drug containing controlled-release oxycodone hydrochloride to limit such approval to use for the relief of severe-only instead of moderate-to-severe pain, and for other purposes.

={{anchor|HCB679FDCD43B4F519BE683E881672C94}}Section 1. Short title=

This Act may be cited as the“Stop Oxy Abuse Act of 2013”.

={{anchor|H7ED4A5F555634C4C843B123EC4414191}}Sec. 2. Limiting approval of drugs containing controlled-release oxycodone hydrochloride to use for relief of severe-only pain=



=={{anchor|H800CE6B9AFC94B4FA05919CD2892D903}}(a) In general– ==

Not later than 90 days after the date of the enactment of this Act, the [[w:Food and Drug Administration|Commissioner of Food and Drugs]] shall take such actions as may be necessary—
:(1) to modify the approval of any drug containing controlled-release oxycodone hydrochloride under section 505 of the Federal Food, Drug, and Cosmetic Act([http://www.law.cornell.edu/uscode/text// 21 U.S.C. 355] )to limit such approval to use for the relief of severe-only instead of moderate-to-severe pain; and
:(2) to limit any subsequent approval of a drug containing controlled-release oxycodone hydrochloride under such section to use for the relief of severe-only pain.

=={{anchor|H208310069E5B4E30850B9B40E8DE143F}}(b) Applicability– ==

Any modification required by subsection (a)(1)shall apply to drugs introduced or delivered for introduction into interstate commerce on or after the date that is 180 days after the date of the enactment of this Act.